Selenate induces epithelial-mesenchymal transition in a colorectal carcinoma cell line by AKT activation (Q39139352)

9 September 2017

title

Selenate induces epithelial-mesenchymal transition in a colorectal carcinoma cell line by AKT activation (English)

1 reference

9 September 2017

1 reference

Takanori Tsukamoto

1 reference

9 September 2017

Susumu Hama

series ordinal

1 reference

9 September 2017

Kentaro Kogure

series ordinal

1 reference

9 September 2017

Hiroyuki Tsuchiya

series ordinal

1 reference

9 September 2017

language of work or name

English

0 references

publication date

11 June 2013

1 reference

Experimental Cell Research

9 September 2017

published in

1 reference

9 September 2017

volume

319

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

1913-1921

1 reference

The human selenoproteome: recent insights into functions and regulation

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Investigation of the selenium metabolism in cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Effects of inorganic selenium compounds on oxidative DNA damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Selenoprotein expression is regulated at multiple levels in prostate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Differential effects of selenite and selenate on human melanocytes, keratinocytes, and melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

The effect of four chemical forms of selenium on mammary tumor incidence in BALB/c female mice treated with 7-12-dimethylbenz[a]anthracene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Inorganic selenium retards progression of experimental hormone refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Serine/threonine phosphatases: mechanism through structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

From promiscuity to precision: protein phosphatases get a makeover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

CD437 induces apoptosis in ovarian adenocarcinoma cells via ER stress signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

The PTEN-PI3K pathway: of feedbacks and cross-talks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Regulation of Raf-1 by direct feedback phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.031

10.1016/J.YEXCR.2013.05.031

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference